Discovering fragment length signatures of circulating tumor DNA using Non-negative Matrix Factorization
Preprint
Abstract
Sequencing of cell-free DNA (cfDNA) is currently being used to detect cancer by searching both for mutational and non-mutational alterations. Recent work has shown that the length distribution of cfDNA fragments from a cancer patient can inform tumor load and type. Here, we propose non-negative matrix factorization (NMF) of fragment length distributions as a novel method to study fragment lengths in cfDNA samples. Using shallow whole-genome sequencing (sWGS) of cfDNA from a cohort of patients with metastatic castration-resistant prostate cancer (mCRPC), we demonstrate how NMF accurately infers the true tumor fragment length distribution as an NMF component - and that the sample weights of this component correlate with ctDNA levels (r=0.75). We further demonstrate how using several NMF components enables accurate cancer detection on data from various early stage cancers (AUC=0.96). Finally, we show that NMF, when applied across genomic regions, can be used to discover fragment length signatures associated with open chromatin.Keywords
All Related Versions
- Published version: eLife, 11.
This publication has 22 references indexed in Scilit:
- The Ensembl Variant Effect PredictorGenome Biology, 2016
- VarDict: a novel and versatile variant caller for next-generation sequencing in cancer researchNucleic Acids Research, 2016
- Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-OriginCell, 2016
- Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgeryGut, 2015
- leeHom: adaptor trimming and merging for Illumina sequencing readsNucleic Acids Research, 2014
- SAMBLASTER: fast duplicate marking and structural variant read extractionBioinformatics, 2014
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human MalignanciesScience Translational Medicine, 2014
- Sensitive detection of somatic point mutations in impure and heterogeneous cancer samplesNature Biotechnology, 2013
- VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencingGenome Research, 2012
- A framework for variation discovery and genotyping using next-generation DNA sequencing dataNature Genetics, 2011